|
|
Volumn 159, Issue , 2002, Pages 143-148
|
|
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADULT;
B CELL LYMPHOMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
PATHOLOGY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
HUMANS;
LYMPHOMA, AIDS-RELATED;
PROGNOSIS;
MLCS;
MLOWN;
|
|
EID: 0036369921
PISSN: 00800015
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-642-56352-2_17 Document Type: Review |
|
Times cited : (7)
|
|
References (19)
|
